LATE-BREAKING ABSTRACT: CFIm25 links alternative polyadenylation to pulmonary hypertension

Harry Karmouty-Quintana (Houston, United States of America), Tingting Weng, Ning-Yuan Chen, Michael Blackburn, Eric Wagner, Harry Karmouty Quintana

Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Session: Pulmonary hypertension: novel insights into the biology of the disease
Session type: Thematic Poster Session
Number: 2428
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Harry Karmouty-Quintana (Houston, United States of America), Tingting Weng, Ning-Yuan Chen, Michael Blackburn, Eric Wagner, Harry Karmouty Quintana. LATE-BREAKING ABSTRACT: CFIm25 links alternative polyadenylation to pulmonary hypertension. Eur Respir J 2015; 46: Suppl. 59, 2428

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Systemic vascular function in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013

LATE-BREAKING ABSTRACT: Evidence for a critical contribution of pericytes in pulmonary arterial hypertension pathogenesis
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Comparison of exercise capacity and exercise haemodynamic relationships between severe group 3 pulmonary hypertension and pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology
Year: 2016

LATE-BREAKING ABSTRACT: Peak oxygen consumption improves in inoperable, but not operable, chronic thromboembolic pulmonary hypertension after treatment with pulmonary arterial hypertension drugs
Source: Annual Congress 2013 –New physiologic boundaries
Year: 2013


Pulmonary hypertension correction in patients with chronic obstructive pulmonary disease and essential hypertension
Source: International Congress 2014 – Pulmonary hypertension in lung disease
Year: 2014


Pulmonary hypertension in COPD
Source: Eur Respir J 2008; 32: 1371-1385
Year: 2008



LATE-BREAKING ABSTRACT: The bromodomain-containing protein 4: the epigenetic origin of the oncogenic signature in pulmonary hypertension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014

Left ventricular-arterial coupling and cardiac remodeling in patients with idiopathic arterial pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


Pulmonary hypertension in patients with COPD
Source: Eur Respir Mon 2012; 57: 138-147
Year: 2012


LATE-BREAKING ABSTRACT: TNFalpha mediates ectodomain shedding of BMPR-II: A potential role in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

Role of tadalafil in patients with hypoxia / lung disease induced (group 3) pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: the clinic I
Year: 2016

Evidence of renal and pulmonary endothelial dysfunction in chronic obstructive pulmonary disease (COPD)
Source: International Congress 2016 – New signalling pathways in COPD
Year: 2016

Pulmonary hypertension in chronic lung disease and hypoxia
Source: Eur Respir J, 53 (1) 1801914; 10.1183/13993003.01914-2018
Year: 2019



LATE-BREAKING ABSTRACT: The effect of volume overload on pulmonary hypertension in hemodialysis patients
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015


LATE-BREAKING ABSTRACT: Riociguat for the treatment of chronic thromboembolic pulmonary hypertension (CTEPH): 2-year results from the CHEST-2 long-term extension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014


The effect of chronic dosing of riociguat on acute hypoxic pulmonary vasoconstriction in respiratory disease
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016

Challenging cases in PH
Source: Eur Respir Rev 2008; 17: 19-23
Year: 2007



Cardiac remodeling and left ventricular-arterial coupling in patients with chronic thromboembolic pulmonary hypertension
Source: International Congress 2015 – Pulmonary circulation: the story of fresh and old clots
Year: 2015


Pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: pathophysiology
Source: Eur Respir Rev 2009; 19: 59-63
Year: 2010